Skip to content
FIND A HEALTH VALLEY ACTOR

Debiopharm leads $6M round for YonaLink to Scale Global Growth

Debiopharm Yona Link

The swiss company invests into an Israelian SaaS Platform able to collect data and to reduce clinical trial timelines and costs     Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and YonaLink, a clinical trial software provider, announced having completed an initial funding round, raising $6 million, to scale global…

Read More

Bone marrow neurons can be rewired to enable paraplegics to walk

Neurorestore

Jocelyne Bloch and Grégoire Courtine, two Swiss researchers, have identified a group of nerve cells unrelated to the locomotor system with the capacity to change function   A new study by scientists at the .NeuroRestore research center has identified the type of neuron that is activated and remodeled by spinal cord stimulation, allowing patients to…

Read More

🔺4à6 BioAlps at Incyte🔺

BioAlps Incyte

  On 22 September 2022, Jonathan Dickinson, executive vice-president at Incyte, received the Swiss Health Valley Community in Morges.   About 70 people participated at the BioAlps 4à6 event at Incyte, and had the opportunity to listen to: Ela Zawislak, Head of Public Affairs, Incyte EuropeHead of Public Affairs, Incyte Europe Incyte Ekaterine Asatiani, Division…

Read More

Novochizol SA and Alpha Chitin Partner to Produce a Chitosan-Based Polysaccharide

Novochizol Alpha Chitin

Alpha Chitin will manufacture both Novochizol™ raw materials and Novochizol™-based intermediate products.   Alpha Chitin, a French biobased chemistry company (Lacq – Aquitaine) and producer of innovative high-quality chitosans, and Novochizol SA, a Swiss biotech (Monthey – Valais) with a unique chitosan processing technology, today announced the creation of a joint venture to realize the…

Read More

SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis

Sofia Genetics Microsft

The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data analysis platform available with Microsoft Azure   SOPHiA GENETICS™ (Nasdaq: SOPH), a cloud-native software company in the healthcare sector based in Lausanne (Switzerland), is embarking on a multi-year integrated strategic partnership with Microsoft to improve healthcare workflows globally. This investment in…

Read More

Interview Prof. Yogeshvar Kalia

Prof Kalia

Prof. Yogeshvar Kalia is Professor at the Faculty of Pharmaceutical Sciences at the University of Geneva (UNIGE) speaks about the necessity to create more bridges between the Academic World and the Industry.   ✅ Collaboration between academic institutions and industries is key ✅ DeepTech and discoveries are done in Universities, Big Pharma companies focus drug…

Read More

How does the microbiota work?

Microbiome

Researchers at the University of Bern and University Hospital Bern have been able to comprehensively study the bacteria of the small intestine. The findings contribute to a better understanding of intestinal diseases such as Crohn’s disease or celiac disease and to the development of new therapeutic approaches.   Humans have just as many microbes in…

Read More

A new test to avoid miscarriages and strokes

HUG Endotelix

The HUG and the Unige have found a way to better detect the antibodies that cause thrombosis, which leads to strokes and heart attacks, in young and pregnant women.   At least 15% of miscarriages are due to an autoimmune disease called antiphospholipid syndrome. It affects between 1 and 5% of the world population. And…

Read More

Cordis spends 1.14 billion francs to buy MedAlliance

MedAlliance

Nyon-based MedAlliance, a start-up active in the field of vascular medical technology, has been acquired by the American multinational Cordis for 1.14 billion francs.   Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and upfront closing payment of…

Read More

Netsensing Technology finalists of the 14th Healthcare Innovation World Cup at Medica 2022

NeSensing

Incubated at Microcity Neuchâtel, Netsensing Technology is excited to announce that it has been selected as one of the Top12 Health Techpreneurs 2022.   Netsensing Technology is presenting its solution in an exciting final during the 14th Healthcare Innovation World Cup® Pitch and Award Ceremony at MEDICA in Dusseldorf, the world’s largest medical trade fair…

Read More